ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Ulcer
Obesity

Diabetes trials near Rochester, MN, USA:

R-5280 in Newly Diagnosed Patients With Type 1 Diabetes

Evaluating the adverse events and tolerance of R-5280 in Mitigating Type 1 Diabetes in Newly Diagnosed Patients...

Enrolling
Diabetes Mellitus, Type 1
Type 1 Diabetes
Other: Placebo
Drug: R-5280

Phase 1

Rise Therapeutics

Rochester, Minnesota, United States and 1 other location

are interested to evaluate the effect of BKR-017 (colon-targeted 500 mg butyrate tablets) as adjuvant therapy on metabolic control in type 1 diabetes...

Enrolling
Type1diabetes
Drug: BKR-017

Phase 1, Phase 2

Mayo Clinic
Mayo Clinic

Rochester, Minnesota, United States

The purpose of this study is to collect clinical data to support a 7-day wear of the Extended Wear Infusion Set (EWIS).Participants will be asked to:...

Active, not recruiting
Type1diabetes
Device: SteadiSet Extended Wear Infusion Set
Tandem Diabetes Care
Tandem Diabetes Care

Rochester, Minnesota, United States and 14 other locations

Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...

Enrolling
Type 1 Diabetes
Device: Subject's Current Diabetes Therapy
Device: 670G and 770G Insulin Pump
Medtronic
Medtronic

Rochester, Minnesota, United States and 37 other locations

for endoscopic duodenal mucosal regeneration in patients with type 2 Diabetes inadequately controlled on 2-3 non-insulin glucose-lowering me...

Active, not recruiting
Diabetes
Diabetes Mellitus
Device: The Endogenex Device
Endogenex

Rochester, Minnesota, United States and 2 other locations

fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community ...

Enrolling
Diabetic Retinopathy
Other: Placebo
Drug: Fenofibrate

Phase 3

Jaeb Center for Health Research
Jaeb Center for Health Research

Rochester, Minnesota, United States and 60 other locations

cortisol-secreting adrenal adenoma or hyperplasia associated with diabetes mellitus/ impaired glucose tolerance and/or uncontrolled systolic...

Active, not recruiting
Hypercortisolism
Drug: relacorilant
Other: Placebo

Phase 3

Corcept Therapeutics
Corcept Therapeutics

Rochester, Minnesota, United States and 47 other locations

This study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (...

Enrolling
Obesity
Drug: Matching Placebo-Garetosmab
Drug: Garetosmab

Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Rochester, Minnesota, United States and 50 other locations

This is study with SPI-62 to evaluate the efficacy, safety, and pharmacological effect of SPI-62 in subjects with hypercortisolism related to a benig...

Active, not recruiting
ACTH-Independent Cushing Syndrome
ACTH-Independent Adrenal Cushing Syndrome, Somatic
Drug: SPI-62 dose

Phase 2

Sparrow Pharmaceuticals

Rochester, Minnesota, United States and 4 other locations

Locations recently updated

This is an open-label extension study to evaluate the long-term safety of relacorilant in patients with endogenous Cushing syndrome who successfully...

Invitation-only
Cushing Syndrome
Drug: relacorilant

Phase 2

Corcept Therapeutics
Corcept Therapeutics

Rochester, Minnesota, United States and 51 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems